MiniMed Showcases Flex Pump and Smart Go Pen With New Clinical Data
MMED•MiniMed will showcase its next-generation Flex pump and Go smart pen at the American Diabetes Association Scientific Sessions June 5-8 in New Orleans, marking its first U.S. congress as a standalone public company. The company will present real-world clinical data on its refreshed sensor portfolio and closed-loop systems.
1. Event Overview
MiniMed will attend the American Diabetes Association Scientific Sessions June 5-8 in New Orleans, marking the company’s first U.S. diabetes congress since becoming a standalone public company. The event provides a platform to highlight its advances in automated insulin delivery and connected sensor technologies.
2. Product Demonstrations
At the conference, hands-on demos will allow attendees to explore the MiniMed Flex system, a screenless, smartphone-controlled pump featuring real-time SmartGuard automation, alongside the MiniMed Go smart insulin pen system with dose memory, reminders and personalized recommendations.
3. Clinical Data and Presentations
The company will present emerging clinical data on its refreshed sensor portfolio and advanced closed-loop platforms. Poster sessions will cover topics such as three-year glycemic sustainability with the 780G system, performance of the new Instinct sensor, and glycemic outcomes across diverse patient groups including Medicaid and Medicare beneficiaries.
4. Engagement and Pipeline
Sponsored events include a product theater session and a learning byte, offering insights from company executives and independent experts. An interactive exhibition booth will showcase MiniMed’s full product pipeline, educational programs for healthcare providers, and support offerings for patients.
